View of Isoprinosine along with Favipiravir or Oseltamivir in Patients with Moderate Covid-19 at RSD Dr. Soebandi Jember
Teks penuh
Dokumen terkait
This study included 180 participants who were divided into group A consisted of 60 COVID-19 positive patients with normal level of Vit D3, group B consisted of 60 COVID-19 positive
Despite the fact that our meta-analysis study demonstrated that ozone adjuvant therapy improved clinical variables and laboratory biomarkers in COVID-19 patients, except for mortality
Volume 06, Issue 11, November 2021, https://doi.org/10.23958/ijirms/vol06-i11/1230 Case Series Convalescent Plasma Therapy for pregnant patients with COVID-19: Case Series Mariam
Similarly, a multicenter, open-label, randomized clinical trial on patients with mild to moderate COVID-19 demonstrated that early treatment with combination therapy of
Based on the overall fatality of COVID-19 statistics, studies have found that risk for severe illness with COVID-19 increases with age, with older adults and patients with comorbidities
92 Original Research Report CLINICAL PROFILES AND IL-6 LEVEL ANALYSIS OF CRITICAL COVID-19 PATIENTS RECEIVING LOPINAVIR-RITONAVIR Erwin Astha Triyono1,2* , Nancy Margarita Rehatta3
To analyse the average duration of hospitalisation of patients on remdesivir therapy To gauge the final outcome of admission of COVID- 19 pneumonia patients on remdesivir therapy
Allergy history varied between adult and child asthma exacerbation patients, with medicine allergies being more prevalent among adults and seafood and cow's milk allergies among
